Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2022

01-03-2022 | Perspective

U.S. Refugee Resettlement Is in Ruins—It Is Our Duty to Rebuild It

Author: Matthew L. Lorenz, MD

Published in: Journal of General Internal Medicine | Issue 4/2022

Login to get access

Abstract

Beginning in 2017, policy changes impacting the U.S. Refugee Admissions Program (USRAP) led to dramatic cuts in U.S. refugee resettlement. These changes have impeded relief of humanitarian crises, compromising the safety of tens of thousands of refugees eligible for resettlement and delaying family reunification. Rebuilding USRAP will require significant funding, support, and time. Such rebuilding is a necessary step in addressing the global refugee crisis and a potential life-saving intervention for many refugees, who suffer a range of threats and maladies. Many have chronic untreated medical issues and untold psychological trauma—physical and emotional wounds from years of persecution. They need—and deserve—our help.
Literature
4.
go back to reference Executive Office of the President. Protecting the Nation From Foreign Terrorist Entry Into the United States. Fed Regist. 2017 Feb 1;82(20):8977-8982. Executive Office of the President. Protecting the Nation From Foreign Terrorist Entry Into the United States. Fed Regist. 2017 Feb 1;82(20):8977-8982.
7.
go back to reference Executive Office of the President. Improving Enhanced Vetting Capabilities and Processes for Detecting Attempted Entry Into the United States by Terrorists or Other Public-Safety Threats. Fed Regist. 2020 Feb 5;85(24):6699-6707. Executive Office of the President. Improving Enhanced Vetting Capabilities and Processes for Detecting Attempted Entry Into the United States by Terrorists or Other Public-Safety Threats. Fed Regist. 2020 Feb 5;85(24):6699-6707.
Metadata
Title
U.S. Refugee Resettlement Is in Ruins—It Is Our Duty to Rebuild It
Author
Matthew L. Lorenz, MD
Publication date
01-03-2022
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 4/2022
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-021-07373-5

Other articles of this Issue 4/2022

Journal of General Internal Medicine 4/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.